English
Home > Products > 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline

China 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline Factory

The key to our success is "Good Product Quality, Reasonable Value and Efficient Service" for 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline,CAS NO 1609394-10-6,1609394-10-6,Deucravacitinib intermediate,Deucravacitinib advance intermediate, We warmly welcome all intrigued shoppers to make contact with us for more data.
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline, Our factory is equipped with complete facility in 10000 square meters, which makes us be able to satisfy the producing and sales for most auto part products and solutions. Our advantage is full category, high quality and competitive price! Based on that, our goods win a high admiration both at home and abroad.

Related Products

Hot Products

  • Cytarabine

    Cytarabine

    Product Name:Cytarabine
    Molecular Formula:C9H13N3O5
    Molecular Weight:243.22
    CAS Registry Number:147-94-4
  • 6-Chloroguanine

    6-Chloroguanine

    Product Name:6-Chloroguanine
    Molecular Formula:C5H4ClN5
    Molecular Weight:169.57
    CAS Registry Number:10310-21-1
  • Entecavir Monohydrate

    Entecavir Monohydrate

    Product Name:Entecavir Monohydrate
    Molecular Formula:C12H17N5O4
    Molecular Weight:295.3
    CAS Registry Number:209216-23-9
  • 2-Chloro-N-(2,6-dimethylphenyl)acetamide

    2-Chloro-N-(2,6-dimethylphenyl)acetamide

    Product Name:2-Chloro-N-(2,6-dimethylphenyl)acetamide
    Molecular Formula:C10H12ClNO
    Molecular Weight:197.66
    CAS Registry Number:1131-01-7
  • Diethyl 2-propylImidazoledicarbonate

    Diethyl 2-propylImidazoledicarbonate

    Product Name:Diethyl 2-propylImidazoledicarbonate
    Molecular Formula:C12H18N2O4
    Molecular Weight:254.28
    CAS Registry Number:144689-94-1
  • N6-Cbz-L-Lysine

    N6-Cbz-L-Lysine

    Product Name:N6-Cbz-L-Lysine
    Molecular Formula:C14H20N2O4
    Molecular Weight:280.32
    CAS Registry Number:1155-64-2
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept